Medical/Pharmaceuticals

AACR OVARIAN CANCER CONFERENCE PRESENTATION

HIGHLIGHTS * Data from preclinical studies in ovarian cancer presented at premier international conference inBoston, USA.  * Results indicate that Amplia's proprietary FAK inhibitor narmafotinib (AMP945) performs better than standard-of-care in models of chemotherapy-resistant high-grade ser...

2023-10-09 15:18 1373

Over 1,100 exhibitors commit to attend 2024 China Association of Clinical Laboratory Practice Expo (CACLP) and China IVD Supply Chain Expo (CISCE)

* The 21st edition of CACLP and the 4th edition of CISCE will take place from 16 - 18 March at Chongqing International Expo Center, China. * Concurrent with the tradeshows, the 9th China Experimental Medicine Conference and Series Sessions, the 11th China IVD Industry Development Conference a...

2023-10-09 15:16 1931

Innovent Announces First Patient Dosed in the Phase 3 Clinical Study (STAR) of Efdamrofusp Alfa (IBI302), a First-in-class Ophthalmic Anti-VEGF and Anti-Complement Bispecific Fusion Protein for the Treatment of Neovascular Age-related Macular Degeneration

ROCKVILLE, Md. and SUZHOU, China, Oct. 9, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and...

2023-10-09 08:00 5930

CANbridge Announces Marketing Approval of CAN108 (/LIVMARLI®) in Taiwan for the Treatment of Cholestatic Pruritus in Patients with Alagille Syndrome (ALGS)

* LIVMARLI is the First and Only Treatment Approved in Taiwan for Cholestatic Pruritus in ALGS * LIVMARLI is approved for Cholestatic Pruritus in ALGS in the US, Canada, Europe, Mainland China, and other regions globally BEIJING and BURLINGTON, Mass. ,Oct. 8, 2023 /PRNewswire/ -- CANbridge Pha...

2023-10-09 08:00 1544

Xinhua Silk Road: Xinhua-Hengshan Astragalus Membranaceus Market Index unveiled in China's Shanxi

BEIJING, Oct. 8, 2023 /PRNewswire/ -- The Xinhua-Hengshan Astragalus Membranaceus Market Index was recently unveiled in Hunyuan County, northChina's Shanxi Province. Xinhua-Hengshan Astragalus Membranaceus Market Index unveiled in China’s Sha...

2023-10-08 10:02 5508

Agilent and Sarawak Infectious Disease Centre Partner to Boost Neglected Tropical Diseases Research in East Malaysia

KUALA LUMPUR, Malaysia, Oct. 6, 2023 /PRNewswire/ -- Agilent Technologies Inc.  (NYSE:...

2023-10-06 13:26 3172

FDA Grants Orphan Drug Designation to GC Biopharma's Drug Candidate for Thrombotic Thrombocytopenic Purpura

YONGIN, South Korea, Oct. 5, 2023 /PRNewswire/ -- GC Biopharma Corp. announced today that GC1126A, its drug candidate for Thrombotic Thrombocytopenic Purpura (TTP), received an Orphan Drug Designation onSeptember 27 from the U.S. Food and Drug Administration (FDA). When designated as an orphan...

2023-10-06 08:12 2433

STARmed America Launches, Pioneering Thermal Ablation Innovations in North America

LOS ANGELES, Oct. 5, 2023 /PRNewswire/ -- STARmed Co., Ltd ., a leading South Korean medical device company, officially launched its U.S. subsidiary,STARmed America , on October 1st, 2023. This strategic move underscores STARmed's commitment ...

2023-10-05 20:00 1859

Everest Medicines' Partner Calliditas Presents New Data from the NefIgArd Phase 3 Trial at the 17th International Symposium on IgA Nephropathy Tokyo 2023

SHANGHAI, Oct. 5, 2023 /PRNewswire/ -- Everest Medicines' (HKEX 1952.HK, "Everest", or the "Company") partner Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) ("Calliditas") presented new biomarker and subgroup analyses from Nefecon®'s Phase 3 NefIgArd study in both posters and ...

2023-10-05 07:33 2202

Amcor's AmSky™ and AmPrima™ earn Walmart's 'Circular Connector' seal of approval

ZURICH, Oct. 4, 2023 /PRNewswire/ -- Amcor (NYSE: AMCR, ASX: AMC), a global leader in developing and producing responsible packaging solutions, has been recognized for itsAmSky™  andAmPrima™

2023-10-04 23:55 5473

Large-scale proteomics in population-based studies from UK and Iceland

REYKJAVIK, Iceland, Oct. 4, 2023 /PRNewswire/ -- In a paper released today, deCODE Genetics' scientists shared their findings from a plasma proteomics study performed using affinity-based methods. They analyzed the proteins in the context of diseases and diversity in the sequence of the genome an...

2023-10-04 23:00 2313

Kensing to Acquire AOM

Acquisition expands Kensing's Natural Vitamin E and phytosterols product offerings. KANKAKEE, Ill., Oct. 4, 2023 /PRNewswire/ -- Kensing, LLC ("Kensing" or the "Company"), a leading manufacturer of Natural Vitamin E, Plant Sterols and high-purity surfactants, and a portfolio company owned by an ...

2023-10-04 21:00 2930

LOTTE BIOLOGICS Announces Land Purchase Agreement with Incheon Free Economic Zone Authority, Establishing New Foothold in Songdo

* Construction of a Bio Plant with a total production capacity of 360 kL at Songdo's Block KI20, Zone 11 by 2030 * Aims to secure capabilities of an international standard and expand client base by making the Bio Plant a key hub SEOUL, South Korea, Oct. 4, 2023 /PRNewswire/ -- LOTTE BIOLOGICS...

2023-10-04 18:14 1595

IN HONOR OF WORLD MENTAL HEALTH DAY, SEPHORA COMMITS TO DONATING 100 PERCENT* OF RARE BEAUTY BY SELENA GOMEZ PRODUCT SALES TO THE RARE IMPACT FUND

On October 10, 100%* of all Rare Beauty product sales sold at SEPHORA locations worldwide. SINGAPORE, Oct. 4, 2023 /PRNewswire/ -- Today, SEPHORA and Rare Beauty announce the launch of the Make a Rare Impact campaign, a partnership in recognition of World Mental Health Day, an international day ...

2023-10-04 18:00 3049

FDA Grants Transcenta Clearance to Proceed with Global Phase III Trial of Osemitamab (TST001) as First-Line Treatment for Gastric/Gastroesophageal Cancer Patients

Osemitamab (TST001) on Track to Become a Global Therapy that Elevates the Current Standard of Care for HER2-Negative G/GEJ Adenocarcinoma PRINCETON, N.J. and SUZHOU, China, Oct. 4, 2023 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical co...

2023-10-04 08:00 2174

Novavax 2023-2024 COVID-19 Vaccine Now Authorized and Recommended for Use in the U.S.

* This Emergency Use Authorization and CDC recommendation makes Novavax's vaccine the only protein-based non-mRNA COVID vaccine option in the U.S. * Novavax expects doses will be available in thousands of locations across the U.S. in the coming days, including CVS Pharmacy and Rite Aid * Fin...

2023-10-04 04:25 2460

How to Lose Weight Fast and Improve Your Mental Health at Gowalking.com

BOCA RATON, Fla., Oct. 3, 2023 /PRNewswire/ -- Gowalking.com is on a mission to help you achieve your health and wellness goals. Gowalking.com offers a comprehensive platform for finding walking clubs near you and anywhere you travel giving you the opportunity to meet new friends wherever you go....

2023-10-03 22:22 2561

First patient treated with Cu-67 SAR-Bombesin in theranostic prostate cancer trial

SYDNEY, Oct. 3, 2023 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for children and adults with cancer, is pleased to announce the dosing of the first ...

2023-10-03 20:58 1979

Menarini Silicon Biosystems announces new study results on use of CELLSEARCH® liquid biopsy for earlier detection of relapse and to help inform decisions on patient management in stage III Melanoma

Results of this MD Anderson study were recently published in Cancers and indicate the relevance of enumeration of Circulating Tumor Cells (CTCs) with the minimally invasive liquid biopsy-based CELLSEARCH® system to gain significantly earlier information, compared to standard imaging techniques, o...

2023-10-03 20:00 1937

DrinkAid Marks Its Third Anniversary with an Exclusive Partnership with Singapore's Top Artistic Talent -- Tobyato, Jaeyelle, and JONT

SINGAPORE, Oct. 3, 2023 /PRNewswire/ -- DrinkAid, Singapore's pioneering health supplement brand that alleviates the side effects of alcohol, marks its third anniversary with an exclusive partnership withSingapore's top artistic talent — Tobyato, Jaeyelle, and JONT.  The limited edition boxes, r...

2023-10-03 09:00 2513
1 ... 140141142143144145146 ... 611